<div id="readability-page-1"><p>Acadia Healthcare Company, Inc. ((ACHC)) has held its Q4 earnings call. Read on for the main highlights of the call.</p><h3>Claim 50% Off TipRanks Premium</h3><ul><li>Unlock  hedge fund-level data  and  powerful investing tools  for smarter, sharper decisions  </li><li> Stay ahead of the market with  the latest news and analysis  and maximize your portfolio's potential</li></ul> <p>Acadia Healthcare’s latest earnings call struck a cautiously optimistic tone, as management showcased solid revenue and EBITDA growth, robust bed expansion and a clear path toward positive free cash flow, while also facing sizable headwinds from liability reserves, policy changes and slower‑than‑planned ramp‑ups at newer facilities. Executives stressed tighter capital discipline, operational fixes and quality initiatives as the levers to unlock what they see as substantial embedded earnings power.</p> <h2>Revenue Growth and Earnings Beat</h2> <p>Acadia reported fourth‑quarter revenue of $821.5 million, a 6.1% increase from a year earlier that reflected stronger volumes across its behavioral health facilities. Full‑year 2025 revenue reached $3.31 billion, rising 5% and landing slightly above the high end of prior guidance, signaling that demand remains resilient despite regulatory and operational challenges.</p> <h2>Adjusted EBITDA Near Top of Range</h2> <p>Profitability tracked close to expectations, with fourth‑quarter adjusted EBITDA coming in at $99.8 million. For the full year, adjusted EBITDA was $608.9 million, essentially at the upper end of the company’s $601 million to $611 million guidance range and suggesting that cost controls and mix helped offset some of the external pressures.</p> <h2>Same‑Facility Performance Improves</h2> <p>Underpinning results was better performance at existing hospitals, where fourth‑quarter same‑facility revenue grew 4.4% year over year. That improvement was driven by a 1.3% increase in revenue per patient day and a 3.1% rise in patient days, supporting same‑facility adjusted EBITDA of $152 million in the quarter and indicating healthier utilization trends.</p> <h2>Significant Capacity Expansion Strategy</h2> <p>Acadia continued to lean into growth, adding 1,089 beds in 2025, above the high end of its target and including 778 beds from six new facilities. The company has opened more than 2,500 beds over the past three years and, despite recent closures, still expects to bring on another 400 to 600 beds in 2026, positioning the network for long‑term volume gains.</p> <h2>Embedded EBITDA From New Facilities</h2> <p>Management highlighted what it views as a large earnings opportunity embedded in recently opened hospitals, estimating more than $200 million of incremental EBITDA potential from facilities launched between 2023 and 2026. The company expects that upside to be realized over roughly five years as occupancy ramps and operations mature, although the pace will depend on execution and local market dynamics.</p> <h2>CapEx Discipline and Free Cash Flow Turn</h2> <p>Capital spending came in lighter than planned, with 2025 CapEx of $572 million coming in nearly $50 million below prior guidance. For 2026, the company plans to cut CapEx sharply to a range of $255 million to $280 million and, with growth spend moderating, now expects to generate positive free cash flow for the year, a key milestone for investors focused on leverage and liquidity.</p> <h2>Lower Investigation Costs and Solid Liquidity</h2> <p>Costs tied to the ongoing government investigation fell steeply to $12 million in the fourth quarter, down 69% sequentially, easing one source of earnings drag. Liquidity remains ample, with $133.2 million of cash on hand at year‑end and roughly $595 million available under a $1 billion revolving credit facility, leaving net leverage at about four times adjusted EBITDA.</p> <h2>Operational and Quality Overhaul</h2> <p>The returning chief executive laid out a renewed focus on operational discipline, deepening the leadership bench and standardizing the playbook for new hospital openings. Acadia is also rolling out expanded quality dashboards tracking more than 50 measures and publishing early outcomes data, aiming to tighten performance management and strengthen its position with regulators and payers.</p> <h2>PLGL Reserve and Expense Headwinds</h2> <p>Results were weighed down by a $52.7 million fourth‑quarter adjustment to the professional and general liability reserve, reflecting higher anticipated claims costs. Looking ahead, PLGL expense is expected to run between $100 million and $110 million in 2026, representing a meaningful ongoing drag on profitability and cash generation until trends stabilize.</p> <h2>New York Medicaid Policy Impact</h2> <p>A policy shift in New York that bars out‑of‑state Medicaid patients will hit Acadia’s bottom line and footprint. Management estimates the change will reduce annual EBITDA by $25 million to $30 million in 2026 and has already prompted consolidations and closures in the affected markets as the company reshapes its network to reflect the new rules.</p> <h2>Start‑Up Losses and Slower Ramps</h2> <p>Aggressive expansion has brought sizeable start‑up losses, which totaled $12.8 million in the fourth quarter and $56 million for 2025. For 2026, the company expects start‑up losses of $47 million to $53 million, with some newer facilities ramping more slowly than anticipated and delaying the timing of expected EBITDA contributions.</p> <h2>Facility Closures and Associated Costs</h2> <p>In 2025, Acadia closed five facilities totaling 382 beds, including two leased sites shuttered in response to the New York policy change. The company recorded $3.6 million in net operating costs linked to these closures, underlining the near‑term financial impact of portfolio pruning even as management argues it will sharpen focus on higher‑return assets.</p> <h2>Legal and Regulatory Overhang</h2> <p>Despite the reduction in investigation‑related expenses, the company still faces unresolved legal and regulatory matters that could require future cash settlements. Management acknowledged that both the timing and the ultimate size of any resolution remain uncertain, leaving a cloud over the otherwise improving financial trajectory.</p> <h2>Leverage Constraints on Flexibility</h2> <p>With net leverage standing at roughly four times adjusted EBITDA at year‑end, Acadia is operating with limited balance‑sheet flexibility until free cash flow improves. Management signaled that paying down debt and addressing outstanding liabilities will be key priorities before contemplating more aggressive strategic moves or shareholder returns.</p> <h2>Near‑Term Headwinds to Early 2026</h2> <p>Guidance for the first quarter of 2026 builds in several temporary drags, including about $3.7 million in severe‑weather impact and roughly $14 million of start‑up losses. The outlook for Q1 adjusted EBITDA of $130 million to $137 million also assumes recognition of $11 million in out‑of‑period supplemental payments, complicating year‑over‑year comparisons for investors.</p> <h2>One‑Time Revenue Items Fade</h2> <p>Full‑year 2025 revenue benefited from a nonrecurring $34 million boost tied to supplemental payments from Tennessee, giving a one‑time lift to the top line and margins. With no similar items embedded in 2026 guidance, reported growth rates may appear more muted, even as underlying operations continue to improve.</p> <h2>Guidance and Forward‑Looking Outlook</h2> <p>For 2026, Acadia is targeting revenue between $3.37 billion and $3.45 billion, adjusted EBITDA of $575 million to $610 million and adjusted EPS of $1.30 to $1.55, while turning free cash flow positive. The outlook assumes modest same‑facility volume growth, higher revenue per patient day, substantial start‑up losses, elevated PLGL expense and a potential $22 million EBITDA uplift if pending programs are approved, with first‑quarter guidance calling for revenue of $820 million to $830 million.</p> <p>Acadia’s earnings call painted a picture of a company balancing solid demand and a sizable growth runway with tangible financial and regulatory headwinds. Investors will be watching whether the push for operational discipline, capital spending restraint and quality improvements can convert the embedded EBITDA opportunity into cash flow, reduce leverage and gradually lift the overhang from investigations and policy shocks.</p></div>

ACHC

<p>Acadia Healthcare's Q4 earnings call highlighted solid revenue growth of 6.1% year-over-year, reaching $821.5 million, and adjusted EBITDA of $99.8 million. The company plans to expand capacity by adding over 1,000 beds in 2025, despite facing challenges from liability reserves and regulatory changes. Management anticipates a $25 million to $30 million EBITDA reduction due to a New York Medicaid policy shift. Acadia aims for positive free cash flow in 2026, with a focus on operational discipline and quality improvements, while managing start-up losses from new facilities.</p>

Acadia Healthcare Balances Growth Ambition With Rising Risks